Related Experiment Videos
Predicting respiratory failure in sarcoidosis patients
R P Baughman1, D B Winget, E H Bowen
1Department of Internal Medicine, University of Cincinnati Medical Center, OH 45267-0564, USA.
Summary
Identifying patients at risk of respiratory failure from sarcoidosis is crucial. Key indicators include lung fibrosis on chest X-ray and a vital capacity below 1.5 liters, predicting mortality in sarcoidosis patients.
Area of Science:
- Pulmonology
- Internal Medicine
- Rheumatology
Background:
- Sarcoidosis is a multisystem inflammatory disease.
- Mortality in sarcoidosis is predominantly linked to respiratory failure.
- Identifying at-risk patients is essential for proactive management.
Purpose of the Study:
- To identify predictors of respiratory failure-related mortality in sarcoidosis patients.
- To analyze a seven-year experience of patients at the University of Cincinnati Interstitial Lung Disease clinic.
- To characterize patients who succumb to respiratory failure from sarcoidosis.
Main Methods:
- Retrospective analysis of 479 sarcoidosis patients over seven years.
- Comparison of patients who died from respiratory failure with other patient groups.
- Review of chest roentgenograms and pulmonary function tests (vital capacity).
Main Results:
- Overall mortality was 4.6% (22 out of 479 patients).
- Respiratory failure was the leading cause of death (13 patients).
- All patients who died from respiratory failure exhibited lung fibrosis on chest X-ray and had a vital capacity < 2.5 L; most had < 1.5 L.
Conclusions:
- Lung fibrosis on chest roentgenogram is a significant indicator of mortality risk in sarcoidosis.
- A reduced vital capacity, particularly below 1.5 liters, is strongly associated with respiratory failure-related death.
- These findings aid in identifying sarcoidosis patients at high risk for fatal respiratory complications.